— STX-241 is a highly selective, CNS-penetrant, fourth generation epidermal growth factor receptor (“EGFR”) inhibitor designed to address resistance to third generation EGFR inhibitors — — Preclinical data to be presented in 2H 2023; investigational new drug (“IND”) application submission expected in 1H 2024 — — Third development candidate nominated since Scorpion’s founding three years … [Read more…]

NEW YORK–(BUSINESS WIRE)–Investment funds managed by Morgan Stanley Capital Partners (“MSCP”), the middle-market focused private equity team at Morgan Stanley Investment Management, have entered into an agreement to sell Ovation Fertility (“Ovation”) to US Fertility (“USF”). Financial terms of the transaction were not disclosed. Ovation, headquartered in Nashville, Tennessee, is a leading provider of fertility … [Read more…]

-EU and UK filings completed in 2022; submissions validated by EMA and MHRA and the review procedure has begun as of January 2023- BOSTON & ZUG, Switzerland–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced the completion of the rolling Biologics License Applications (BLAs) to the U.S. Food and Drug Administration … [Read more…]

Arizona-Based Medical Massage Pain Management Practice Uses Integrated Platform to Streamline Operational Processes and Improve Patient Experience NEWPORT BEACH, Calif.–(BUSINESS WIRE)–#EHR—Tebra, a leader in practice growth technology and cloud-based clinical and financial software, today announced that Medi+ssage, a pain management practice in Tempe, Arizona, has chosen its complete operating system for practice success. The Tebra … [Read more…]

– Santiago Arroyo, M.D., Ph.D., appointed Chief Development Officer – Jennifer Perry, Pharm.D., promoted to Senior Vice President, Commercial CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointment of Santiago Arroyo, M.D., … [Read more…]

Enabling identification of major neuronal and non-neuronal cell types across all mouse brain regions CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced the launch of its highly anticipated MERSCOPE® PanNeuro Cell Type Predesigned Panel, enabling cellular and sub-cellular analysis of neuronal signaling, activity … [Read more…]

Heritage CBD products have already been approved by the Brazil Health Authority (ANVISA) to distribute and sell in the country TORONTO–(BUSINESS WIRE)–$cann #cann–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that it has received a purchase order from a Brazilian pharmaceutical CBD product importation and distribution company, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Personalized Medicine Biomarkers Market by Indication, by Application, and by Region – Global Forecast to 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The personalized medicine biomarkers market size is estimated to be USD 11,985.2 million in 2022 and is expected to witness a CAGR of 15.86% during the forecast period 2023-2033. Companies … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Nutraceutical Contract Manufacturing Services Market By Dosage Form, By Product, and by Region – Global Forecast to 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The nutraceutical contract manufacturing services market size is estimated to be USD 114.2 billion in 2022 and is expected to witness a CAGR of 12.01% during the forecast … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Gastrointestinal Partnering 2016-2023: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Gastrointestinal Partnering 2016 to 2023 provides the full collection of gastrointestinal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2016. Trends in gastrointestinal partnering deals Financial deal terms for headline, upfront and royalty … [Read more…]